Mark Identification

IPO IMPATH PREDICTIVE ONCOLOGY

Serial Number

76226598

Filing Date

Mar 19, 2001

Registration Date

Jul 1, 2003

Trademark by

GENZYME CORPORATION

Classification Information

Biopharmacogenomic services, namely research and development in targeted drug and diagnostic product discovery, drug development and diagnostic product and targeted therapies for others

Computer and Scientific